| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6960577 | ELI LILLY AND CO | Combination therapy for treatment of refractory depression |
Nov, 2017
(6 years ago) | |
Prozac is owned by Eli Lilly And Co.
Prozac contains Fluoxetine Hydrochloride.
Prozac has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Prozac are:
- US6960577
Prozac was authorised for market use on 23 December, 1992.
Prozac is available in capsule;oral dosage forms.
Prozac can be used as prozac and olanzapine in combination for the acute treatment of treatment resistant depression in adults.
The generics of Prozac are possible to be released after 01 November, 2017.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-589) | Mar 19, 2012 |
| New Patient Population(NPP) | Jul 26, 2016 |
Drugs and Companies using FLUOXETINE HYDROCHLORIDE ingredient
Market Authorisation Date: 23 December, 1992
Treatment: Prozac and olanzapine in combination for the acute treatment of treatment resistant depression in adults
Dosage: CAPSULE;ORAL
PROZAC family patents
